START South Texas Accelerated Research Therapeutics — San Antonio, Texas

START South Texas Accelerated Research Therapeutics is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

START South Texas Accelerated Research Therapeutics has participated in 23 clinical trials with 6 currently active.

Therapeutic areas: Solid Tumors, Advanced Malignancies, Prostate Neoplasms.

Sponsors: Daiichi Sankyo, Regeneron Pharmaceuticals, Janssen Research & Development, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Antonio

Browse all research sites in Texas · View every site in San Antonio

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START South Texas Accelerated Research Therapeutics?

START South Texas Accelerated Research Therapeutics has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START South Texas Accelerated Research Therapeutics conducted?

START South Texas Accelerated Research Therapeutics has 23 clinical trials on record, with 6 currently active. Their work covers Solid Tumors, Advanced Malignancies, Prostate Neoplasms.

Is START South Texas Accelerated Research Therapeutics accredited by Crixeo Clinical Trials?

START South Texas Accelerated Research Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START South Texas Accelerated Research Therapeutics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.